Literature DB >> 27558350

Safety of nanosuspensions in drug delivery.

Lulu Wang1, Juan Du1, Yuqi Zhou1, Yancai Wang2.   

Abstract

Nanosuspension technology is currently undergoing dramatic expansion in pharmaceutical science research and development. However, most of the research efforts generally focus on formulation and potential beneficial description, while the research into potential toxicological effects and implications (i.e., in vivo safety and health effects) is lacking. This review identifies some of the key factors for studying nanosuspension safety and the potential undesired effects related to nanosuspension exposure. The key factors for discussion herein include particle characterization, preparation approach, composition, and excipients of the formulation and sterilization methods. A few comments on the primary and required safety aspects of each administration route are also reviewed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  Drug delivery; Nanosuspension; Nanotoxicology; Safety; Sterilization

Mesh:

Substances:

Year:  2016        PMID: 27558350     DOI: 10.1016/j.nano.2016.08.007

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  12 in total

1.  siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells.

Authors:  Supusson Pengnam; Purin Charoensuksai; Boon-Ek Yingyongnarongkul; Rungnapha Saeeng; Hasan Uludağ; Prasopchai Patrojanasophon; Praneet Opanasopit; Samarwadee Plianwong
Journal:  Pharmaceutics       Date:  2022-06-03       Impact factor: 6.525

Review 2.  Cell-based carrier for targeted hitchhiking delivery.

Authors:  Tonggong Liu; Cheng Gao; Dayong Gu; Huanwen Tang
Journal:  Drug Deliv Transl Res       Date:  2022-05-02       Impact factor: 5.671

3.  Nanocrystal dispersion of DK-I-56-1, a poorly soluble pyrazoloquinolinone positive modulator of α6 GABAA receptors: Formulation approach toward improved in vivo performance.

Authors:  Jelena R Mitrović; Branka Divović; Daniel E Knutson; Jelena B Đoković; Predrag J Vulić; Danijela V Randjelović; Vladimir D Dobričić; Bojan R Čalija; James M Cook; Miroslav M Savić; Snežana D Savić
Journal:  Eur J Pharm Sci       Date:  2020-06-18       Impact factor: 5.112

4.  A novel albumin wrapped nanosuspension of meloxicam to improve inflammation-targeting effects.

Authors:  Qi Li; Fen Chen; Yun Liu; Shihui Yu; Xiumei Gai; Mingzhu Ye; Xinggang Yang; Weisan Pan
Journal:  Int J Nanomedicine       Date:  2018-08-15

5.  Comb-like PEG-containing polymeric composition as low toxic drug nanocarrier.

Authors:  Lesya Kobylinska; Igor Patereha; Natalia Finiuk; Natalia Mitina; Anna Riabtseva; Igor Kotsyumbas; Rostyslav Stoika; Alexander Zaichenko; Sandor G Vari
Journal:  Cancer Nanotechnol       Date:  2018-12-20

Review 6.  Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds.

Authors:  Xin Nie; Zhejie Chen; Lan Pang; Lin Wang; Huajuan Jiang; Yi Chen; Zhen Zhang; Chaomei Fu; Bo Ren; Jinming Zhang
Journal:  Int J Nanomedicine       Date:  2020-12-16

7.  Preparation of hydroxy genkwanin nanosuspensions and their enhanced antitumor efficacy against breast cancer.

Authors:  Hui Ao; Yijing Li; Haowen Li; Yian Wang; Meihua Han; Yifei Guo; Rongxing Shi; Feng Yue; Xiangtao Wang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

8.  Silver sulfadiazine nanosuspension-loaded thermosensitive hydrogel as a topical antibacterial agent.

Authors:  Xiaoya Liu; Hui Gan; Chaoran Hu; Wenzhong Sun; Xiaoxia Zhu; Zhiyun Meng; Ruolan Gu; Zhuona Wu; Guifang Dou
Journal:  Int J Nanomedicine       Date:  2018-12-28

Review 9.  Emerging role of nanosuspensions in drug delivery systems.

Authors:  Shery Jacob; Anroop B Nair; Jigar Shah
Journal:  Biomater Res       Date:  2020-01-15

Review 10.  Nanoscale Formulations: Incorporating Curcumin into Combination Strategies for the Treatment of Lung Cancer.

Authors:  Quhui Wu; Huiping Ou; Yan Shang; Xi Zhang; Junyong Wu; Fuyuan Fan
Journal:  Drug Des Devel Ther       Date:  2021-06-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.